Response to comments by Hønge et al. on our paper titled "Prevalence of hepatitis B markers in Senegalese HIV-1 infected patients"

J Med Virol. 2016 Oct;88(10):1655-6. doi: 10.1002/jmv.24452. Epub 2016 Jun 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • HIV Infections
  • HIV-1*
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B virus / immunology
  • Hepatitis B*
  • Hepatitis C
  • Humans
  • Prevalence

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens